VIVS Organovo Holdings, Inc.: Rasio Kapitalisasi Pasar marang Nilai Buku

VivoSim Labs (VIVS) - logo korporat

Bioprinting ethics aimed at reducing animal testing support the current trend, and the historical market cap-to-book ratio shows that this metric equals -0.21. The high precision of VivoSim Labs Inc (VIVS) organ models inspires confidence among pharmaceutical companies. Growth prospects are tied to R&D contracts and the future validation of diagnostic methods by regulators.

VIVS (Organovo Holdings, Inc.) riwayat Kapitalisasi Pasar marang Nilai Buku saka 25.04.2025 nganti 28.10.2026

Rincian metrik keuangan lan pasar organovo.com (VIVS)

- rega lan prakiraan konsensus rega:
Bagan rega VivoSim Labs|VIVS - Target median analis
- data kapitalisasi pasar:
Kapitalisasi pasar Organovo Holdings Inc.|VIVS - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Organovo|VIVS - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku organovo.com|VIVS - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal VivoSim Labs Inc|VIVS - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Organovo|VIVS - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Organovo Holdings Inc.|VIVS - Utang jangka dawa|Utang jangka cendhak perusahaan Organovo
Pambiji fundamental:Organovo Holdings, Inc.
Sampel barang Organovo

The ratio is calculated as the quotient of the company's market value divided by its equity. This metric determines the premium investors are willing to pay for every dollar of net assets. For VivoSim Labs Inc (VIVS), a high valuation is justified by the scalability of 3D bioprinting and the high margins of repeat testing. The price-to-book ratio trend reflects the balance between growth expectations and fundamental stability.

Pesaing langsung

Abbott Laboratories - Rasio Nilai Pasar marang Nilai Buku|thermofisher.com (TMO) - Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku GE HealthCare Technologies (GEHC)|Rasio Kapitalisasi marang Nilai Buku Mettler-Toledo|WAT (Waters Corp.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku Bio-Techne Inc. (TECH)|Rasio Kapitalisasi Pasar marang Nilai Buku BRKR (Bruker Corporation)|Rasio Kapitalisasi Pasar marang Nilai Buku azenta.com AZTA|Rasio Kapitalisasi Pasar marang Nilai Buku VREX|SMLR: Rasio Nilai Pasar marang Ekuitas|Rasio Nilai Pasar marang Nilai Buku Butterfly iQ|MLAB (Mesa Laboratories Corp.) - Rasio Kapitalisasi marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku QSI (Quantum-Si)|Koefisien Nilai Pasar marang Nilai Buku NNOX|QTRX (Quanterix) - Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku 908 Devices Inc MASS|Rasio Kapitalisasi marang Aset Bersih CapsoVision (CV)|Multiplikator Kapitalisasi Pasar marang Nilai Buku MaxCyte Inc MXCT|Rasio Kapitalisasi Pasar marang Nilai Buku RPID (Rapid Micro)|SEER - Kapitalisasi Pasar marang Nilai Buku|HYPR (Hyperfine) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih FONAR Corp.|DXR - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku MDAI|Rasio Nilai Pasar marang Nilai Buku ACON (Aclarion)|Rasio Kapitalisasi marang Aset Bersih akoyabio.com (AKYA)|THMO: Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Talis Biomedical Corp. TLIS|T2 Biosystems, Inc (TTOO) - Rasio Kapitalisasi Pasar marang Nilai Buku